Evaluating ITI-007 in patients with behavioral disturbances associated with dementia, including Alzheimer's disease.

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 02 May 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

28 Apr 2016 According to Intra-Cellular Therapies media release, the company plans to initiate this trial in the second quarter of 2016.
05 Nov 2015 According to an Intra-Cellular Therapies media release, the company plans to initiate this Phase II trial in the first half of 2016.
15 Jun 2015 According to an Intra-Cellular Therapies media release, the company plans to initiate this Phase II trial in later in 2015, hence the planned initiation date changed from 1 Jan 2015 to 1 Dec 2015.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com